— Know what they know.
Not Investment Advice

IBRX NASDAQ

ImmunityBio, Inc.
1W: -5.0% 1M: -4.1% 3M: -11.0% YTD: +283.2% 1Y: +166.9% 3Y: +133.8% 5Y: -48.8%
$7.22
-0.52 (-6.72%)
 
Weekly Expected Move ±11.1%
$6 $7 $8 $9 $10
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 42 · $7.6B mcap · 114M float · 20.04% daily turnover · Short 62% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
44.8 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -152.1%
Cost Advantage
46
Intangibles
33
Switching Cost
47
Network Effect
82
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. IBRX shows a Weak competitive edge (44.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. Negative ROIC of -152.1% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$12
Low
$12
Avg Target
$12
High
Based on 1 analyst since May 7, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 5Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$13.00
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-08 BTIG $6 $12 +6 +54.6% $7.76
2026-03-04 Piper Sandler Edward Tenthoff $7 $12 +5 +30.4% $9.20
2026-02-23 H.C. Wainwright Initiated $15 +54.6% $9.71
2026-01-20 Piper Sandler Initiated $7 +26.8% $5.52
2025-01-10 BTIG Justin Zelin Initiated $6 +147.9% $2.42
2022-08-03 Jefferies Kelly Shi Initiated $8 +93.9% $4.12

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
1
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. IBRX receives an overall rating of C. Strongest factors: ROE (5/5). Areas of concern: DCF (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

22 Grade D
Profitability
20
Balance Sheet
41
Earnings Quality
18
Growth
52
Value
32
Momentum
50
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. IBRX scores highest in Growth (52/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-6.16
Distress Zone
Piotroski F-Score
4/9
Beneish M-Score
-1.41
Possible Manipulator
Ohlson O-Score
5.17
Bankruptcy prob: 99.4%
High Risk
Credit Rating
B-
Score: 20.0/100
Trend: Stable
Earnings Quality
OCF/NI: 0.34x
Accruals: -126.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. IBRX scores -6.16, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. IBRX scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. IBRX's score of -1.41 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. IBRX's implied 99.4% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. IBRX receives an estimated rating of B- (score: 20.0/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-8.68x
PEG
0.07x
P/S
53.64x
P/B
-8.52x
P/FCF
-26.42x
P/OCF
EV/EBITDA
-44.39x
EV/Revenue
60.37x
EV/EBIT
-40.95x
EV/FCF
-28.55x
Earnings Yield
-10.85%
FCF Yield
-3.79%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. IBRX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
4.111
EBT / EBIT
×
EBIT Margin
-1.474
EBIT / Rev
×
Asset Turnover
0.319
Rev / Assets
×
Equity Multiplier
-0.895
Assets / Equity
=
ROE
172.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. IBRX's ROE of 172.9% is driven by Asset Turnover (0.319), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$7.22
Median 1Y
$4.45
5th Pctile
$0.59
95th Pctile
$33.66
Ann. Volatility
117.0%
Analyst Target
$13.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Richard Adcock
President and CEO
$831,667 $2,787,828 $12,716,953
Patrick Soon-Shiong, M.D.
Global Chief Scientific and Medical Officer
$648,826 $2,787,828 $12,293,255
David Sachs
CFO
$591,711 $836,347 $4,244,543
Regan Lauer Accounting
unting Officer
$338,773 $55,755 $745,313

CEO Pay Ratio

6852:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $12,716,953
Avg Employee Cost (SGA/emp): $1,856
Employees: 79,320

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
79,320
+11564.7% YoY
Revenue / Employee
$1,428
Rev: $113,288,000
Profit / Employee
$-4,430
NI: $-351,398,000
SGA / Employee
$1,856
Avg labor cost proxy
R&D / Employee
$2,621
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -610.0% -660.5% 1.9% 2.0% 2.1% 2.2% 1.2% 1.2% 1.4% 1.3% 1.1% 1.2% 1.2% 1.1% 76.9% 76.0% 68.2% 64.8% 71.1% 1.7% 1.73%
ROA -1.5% -1.6% -1.0% -1.1% -1.1% -1.2% -1.0% -1.0% -1.1% -1.1% -1.3% -1.4% -1.4% -1.4% -93.2% -92.2% -82.7% -78.6% -79.4% -1.9% -1.93%
ROIC -3.6% -3.7% -3.0% -3.1% -3.1% -3.2% -1.6% -1.7% -1.7% -1.7% 2.3% 2.2% 2.2% 2.2% 2.0% 1.8% 1.7% 1.5% -1.5% -1.5% -1.52%
ROCE -1.7% -1.8% -3.4% -3.5% -3.5% -3.6% 2.5% 2.5% 2.7% 2.4% -1.0% -1.1% -1.0% -99.6% -87.7% -87.3% -77.5% -75.8% -54.3% -47.2% -47.22%
Gross Margin 1.0% 1.0% 1.0% -385.3% -168.5% -49.6% -93.2% -16.4% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 99.6% 99.5% 87.1% 88.9% 99.5% 99.46%
Operating Margin -253.4% -1194.5% -203.3% -6855.1% -2274.9% -769.5% -1153.7% -309.9% -2076.7% -977.3% -614.3% -2379.9% -94.9% -13.1% -9.2% -3.9% -2.7% -1.7% -1.7% -1.6% -1.58%
Net Margin -260.4% -1327.7% -234.0% -7344.7% -2702.5% -940.2% -1482.4% -323.2% -3362.9% -1165.6% -1679.1% -3352.7% -128.5% -14.0% -7.8% -7.8% -3.5% -2.1% -1.6% -14.3% -14.31%
EBITDA Margin -241.4% -1210.0% -209.9% -6289.3% -2250.1% -749.3% -998.3% -224.3% -2470.6% -684.0% -1415.6% -2440.9% -87.1% -6.7% -5.3% -5.9% -2.3% -1.1% -81.1% -1.5% -1.48%
FCF Margin -371.0% -500.6% -329.7% -423.6% -737.2% -696.7% -1732.0% -693.1% -654.1% -690.2% -638.8% -1367.0% -325.4% -59.2% -27.0% -12.1% -6.3% -3.9% -2.7% -2.1% -2.11%
OCF Margin -345.6% -460.9% -293.8% -357.1% -614.9% -571.7% -1406.3% -592.0% -566.6% -615.5% -589.6% -1289.5% -313.5% -57.5% -26.5% -11.9% -6.2% -3.9% -2.7% -2.1% -2.09%
ROA 3Y Avg snapshot only -1.32%
ROIC Economic snapshot only -54.96%
Cash ROA snapshot only -58.66%
Cash ROIC snapshot only -2.17%
CROIC snapshot only -2.20%
NOPAT Margin snapshot only -1.46%
Pretax Margin snapshot only -6.06%
R&D / Revenue snapshot only 1.64%
SGA / Revenue snapshot only 1.12%
SBC / Revenue snapshot only 6.84%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -20.69 -13.27 -6.96 -6.03 -3.93 -4.98 -4.91 -1.81 -2.57 -1.84 -5.08 -6.01 -7.26 -4.42 -4.55 -6.28 -6.39 -6.68 -5.58 -9.22 -8.676
P/S Ratio 8454.21 6755.14 2585.09 2759.11 2931.74 3569.65 8526.98 1330.47 2054.27 1514.84 4767.66 11963.92 3319.15 354.12 127.53 82.25 41.43 28.21 17.30 55.87 53.639
P/B Ratio -45.87 -31.86 -9.97 -9.22 -6.11 -8.21 -4.57 -1.74 -2.72 -1.88 -5.05 -6.16 -7.40 -4.42 -3.84 -5.25 -4.79 -4.76 -3.92 -15.77 -8.522
P/FCF -22.79 -13.49 -7.84 -6.51 -3.98 -5.12 -4.92 -1.92 -3.14 -2.19 -7.46 -8.75 -10.20 -5.98 -4.72 -6.81 -6.57 -7.19 -6.36 -26.42 -26.419
P/OCF
EV/EBITDA -23.07 -15.15 -8.68 -7.72 -5.51 -6.87 -8.12 -4.35 -5.34 -4.69 -7.88 -9.02 -10.87 -7.16 -8.28 -10.84 -11.34 -11.53 -11.61 -44.39 -44.385
EV/Revenue 8730.34 7072.81 2936.86 3165.23 3582.33 4159.51 11096.10 2382.67 3095.81 2623.82 5507.63 13487.96 3671.03 416.90 151.56 93.60 47.69 32.50 22.90 60.37 60.375
EV/EBIT -21.79 -14.29 -8.19 -7.29 -5.17 -6.44 -7.56 -4.04 -4.99 -4.38 -7.53 -8.66 -10.45 -6.88 -7.77 -10.20 -10.62 -10.80 -10.85 -40.95 -40.952
EV/FCF -23.53 -14.13 -8.91 -7.47 -4.86 -5.97 -6.41 -3.44 -4.73 -3.80 -8.62 -9.87 -11.28 -7.04 -5.61 -7.75 -7.57 -8.28 -8.42 -28.55 -28.550
Earnings Yield -4.8% -7.5% -14.4% -16.6% -25.4% -20.1% -20.4% -55.2% -38.9% -54.4% -19.7% -16.6% -13.8% -22.6% -22.0% -15.9% -15.7% -15.0% -17.9% -10.8% -10.85%
FCF Yield -4.4% -7.4% -12.8% -15.4% -25.1% -19.5% -20.3% -52.1% -31.8% -45.6% -13.4% -11.4% -9.8% -16.7% -21.2% -14.7% -15.2% -13.9% -15.7% -3.8% -3.79%
PEG Ratio snapshot only 0.065
EV/Gross Profit snapshot only 64.369
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.64 1.64 0.91 0.91 0.91 0.91 0.28 0.28 0.28 0.28 5.05 5.05 5.05 5.05 3.36 3.36 3.36 3.36 5.10 5.10 5.099
Quick Ratio 1.64 1.64 0.91 0.91 0.91 0.91 0.28 0.28 0.28 0.28 5.05 5.05 5.05 5.05 3.21 3.21 3.21 3.21 5.08 5.08 5.084
Debt/Equity -2.30 -2.30 -2.67 -2.67 -2.67 -2.67 -1.62 -1.62 -1.62 -1.62 -1.24 -1.24 -1.24 -1.24 -1.03 -1.03 -1.03 -1.03 -1.76 -1.76 -1.758
Net Debt/Equity
Debt/Assets 1.24 1.24 1.38 1.38 1.38 1.38 2.00 2.00 2.00 2.00 1.44 1.44 1.44 1.44 1.32 1.32 1.32 1.32 1.75 1.75 1.750
Debt/EBITDA -1.12 -1.04 -2.04 -1.95 -1.97 -1.92 -2.21 -2.26 -2.11 -2.33 -1.67 -1.61 -1.65 -1.70 -1.87 -1.87 -2.12 -2.17 -3.93 -4.58 -4.579
Net Debt/EBITDA -0.73 -0.68 -1.04 -0.99 -1.00 -0.97 -1.88 -1.92 -1.80 -1.98 -1.06 -1.02 -1.04 -1.08 -1.31 -1.31 -1.49 -1.52 -2.84 -3.31 -3.313
Interest Coverage -22.06 -21.19 -22.56 -17.41 -13.31 -9.12 -5.55 -4.09 -3.43 -2.66 -3.53 -3.43 -3.20 -2.99 -2.18 -2.33 -2.25 -2.48 -2.12 -1.85 -1.854
Equity Multiplier -1.85 -1.85 -1.94 -1.94 -1.94 -1.94 -0.81 -0.81 -0.81 -0.81 -0.86 -0.86 -0.86 -0.86 -0.78 -0.78 -0.78 -0.78 -1.00 -1.00 -1.005
Cash Ratio snapshot only 3.932
Debt Service Coverage snapshot only -1.710
Cash to Debt snapshot only 0.277
FCF to Debt snapshot only -0.340
Defensive Interval snapshot only 264.7 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.03 0.07 0.13 0.19 0.26 0.32 0.319
Inventory Turnover 0.00 0.01 0.05 1.04 1.87 1.91 1.906
Receivables Turnover 0.63 0.55 0.56 0.49 0.30 0.33 0.15 0.36 0.37 0.35 0.32 0.15 0.67 3.75 6.73 14.26 25.85 37.70 5.04 6.28 6.275
Payables Turnover 0.34 0.34 0.00 0.47 0.99 1.51 1.49 1.55 1.18 0.81 0.42 0.00 0.00 0.00 0.00 0.01 0.02 0.54 1.25 1.28 1.277
DSO 576 662 652 753 1206 1093 2451 1004 994 1058 1147 2362 545 97 54 26 14 10 72 58 58.2 days
DIO 0 0 0 0 0 0 0 0 0 0 26028 7782 349 196 192 191.5 days
DPO 1077 1077 774 369 242 245 236 309 450 878 50093 14976 672 292 286 285.8 days
Cash Conversion Cycle -501 -415 -21 837 851 2206 768 684 608 269 -24039 -7181 -313 -24 -36 -36.1 days
Fixed Asset Turnover snapshot only 0.955
Operating Cycle snapshot only 249.7 days
Cash Velocity snapshot only 0.581
Capital Intensity snapshot only 3.560
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue -57.6% -66.2% 20.8% 8.3% -22.3% -1.4% -74.3% -27.6% 17.2% -0.2% 1.6% -48.5% 1.2% 12.2% 22.7% 102.4% 42.3% 10.3% 6.7% 3.5% 3.52%
Net Income -1.1% -63.1% -86.2% -61.7% -41.7% -38.9% -20.1% -16.2% -25.8% -14.6% -40.0% -39.7% -26.3% -28.3% 29.1% 31.9% 38.6% 40.7% 15.0% -1.1% -1.09%
EPS -1.1% -59.5% -79.7% -55.6% -37.0% -36.1% -18.2% -8.0% -14.4% 8.0% 4.3% 11.0% 19.6% 8.4% 43.0% 46.3% 52.5% 56.3% 36.9% -73.5% -73.55%
FCF -1.2% -1.1% -77.6% -63.6% -54.4% -37.2% -35.0% -18.5% -4.0% 1.1% 4.4% -1.7% -9.9% -13.1% -0.2% 8.7% 16.2% 25.4% 22.6% 20.9% 20.90%
EBITDA -1.2% -64.4% -86.0% -57.6% -33.6% -27.8% -3.8% 3.3% -4.5% 7.7% -32.6% -40.8% -28.6% -37.2% 37.9% 40.3% 46.1% 45.5% 17.2% 28.9% 28.86%
Op. Income -1.2% -61.9% -79.1% -45.3% -24.1% -22.6% -6.2% -7.7% -11.4% -4.5% -3.3% 5.6% 3.1% 0.3% 5.0% 9.4% 20.7% 27.6% 25.6% 16.6% 16.60%
OCF Growth snapshot only 20.47%
Asset Growth snapshot only 31.07%
Debt Growth snapshot only 74.17%
Shares Change snapshot only 20.36%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.8% 1.2% 1.7% 1.6% 1.0% 1.4% -36.9% -19.3% -27.2% -30.7% -7.0% -26.1% 26.3% 1.3% 1.5% 2.4% 3.8% 4.3% 6.8% 5.2% 5.22%
Revenue 5Y 73.0% 66.6% 84.2% 75.2% 58.2% 64.0% 39.8% 71.9% 82.8% 60.6% 67.6% 45.1% 85.2% 1.8% 72.9% 94.8% 1.1% 1.2% 1.7% 1.9% 1.85%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 1.7% 1.5%
Gross Profit 5Y 84.2% 45.1% 85.2% 1.8% 72.9% 94.7% 1.1% 1.2%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y -4.0% -4.0% 37.1% 37.1% 37.1% 37.1% 36.3% 36.3% 36.3% 36.3% 31.6% 31.6% 31.6% 31.6% -6.5% -6.5% -6.5% -6.5% 11.5% 11.5% 11.47%
Assets 5Y -9.6% -9.6% 8.1% 8.1% 8.1% 8.1% 7.7% 7.7% 7.7% 7.7% 22.6% 22.6% 22.6% 22.6% 21.8% 21.8% 21.8% 21.8% 17.8% 17.8% 17.79%
Equity 3Y
Book Value 3Y
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.39 0.32 0.71 0.54 0.19 0.16 0.08 0.21 0.03 0.01 0.15 0.11 0.76 0.47 0.38 0.39 0.40 0.45 0.49 0.54 0.544
Earnings Stability 0.12 0.27 0.51 0.62 0.72 0.80 0.82 0.86 0.90 0.93 0.94 0.96 0.99 0.99 0.76 0.71 0.57 0.47 0.24 0.70 0.702
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.00 0.50 0.00 1.00 0.50 1.00 0.50 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.83 0.84 0.92 0.94 0.90 0.94 0.84 0.84 0.89 0.89 0.88 0.87 0.85 0.84 0.94 0.50 0.500
Earnings Smoothness
ROE Trend
Gross Margin Trend -3.46 -3.98 1.45 -5.18 -20.73 -29.10 -99.35 -37.92 -19.36 -6.13 40.31 24.73 27.38 27.37 55.45 21.38 16.15 11.78 4.97 -0.06 -0.061
FCF Margin Trend 250.79 344.45 -183.24 -246.67 -515.80 -406.89 -1454.93 -341.01 -100.04 -91.59 392.04 -808.70 370.24 634.26 1158.39 1017.98 483.45 370.80 330.19 687.44 687.441
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.85 0.91 0.79 0.78 0.83 0.80 0.81 0.81 0.71 0.75 0.63 0.65 0.69 0.72 0.95 0.90 0.95 0.92 0.87 0.34 0.345
FCF/OCF 1.07 1.09 1.12 1.19 1.20 1.22 1.23 1.17 1.15 1.12 1.08 1.06 1.04 1.03 1.02 1.02 1.02 1.01 1.01 1.01 1.013
FCF/Net Income snapshot only 0.349
CapEx/Revenue 25.3% 39.8% 35.9% 66.5% 122.2% 125.0% 325.7% 101.1% 87.5% 74.7% 49.2% 77.5% 11.9% 1.7% 46.7% 21.6% 12.6% 5.2% 2.7% 2.7% 2.65%
CapEx/Depreciation snapshot only 0.232
Accruals Ratio -0.22 -0.15 -0.21 -0.24 -0.19 -0.24 -0.19 -0.20 -0.33 -0.28 -0.50 -0.49 -0.43 -0.38 -0.05 -0.09 -0.04 -0.07 -0.11 -1.27 -1.266
Sloan Accruals snapshot only 0.243
Cash Flow Adequacy snapshot only -78.777
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.1% 0.1% 0.1% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.1% -1.0% -1.6% -1.8% -2.8% 0.0% -2.9% -13.8% -10.0% -14.2% -2.3% -0.6% -0.3% -0.5% -5.9% -4.3% -12.0% -12.1% -11.6% -5.8% -5.82%
Total Shareholder Return 0.1% -1.0% -1.6% -1.8% -2.8% 0.0% -2.9% -13.8% -10.0% -14.2% -2.3% -0.6% -0.3% -0.5% -5.9% -4.3% -12.0% -12.1% -11.6% -5.8% -5.82%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.98 0.99 0.99 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.04 1.04 1.04 1.06 1.08 1.11 1.18 1.25 1.29 1.38 1.28 1.28 1.30 1.32 1.44 1.43 1.44 1.40 1.47 4.11 4.111
EBIT Margin -400.74 -494.96 -358.66 -434.04 -693.10 -645.58 -1467.85 -590.19 -620.18 -599.61 -731.44 -1556.69 -351.46 -60.64 -19.50 -9.17 -4.49 -3.01 -2.11 -1.47 -1.474
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.03 0.07 0.13 0.19 0.26 0.32 0.319
Equity Multiplier 418.49 418.49 -1.91 -1.91 -1.91 -1.91 -1.21 -1.21 -1.21 -1.21 -0.84 -0.84 -0.84 -0.84 -0.82 -0.82 -0.82 -0.82 -0.89 -0.89 -0.895
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.69 $-0.73 $-0.87 $-0.93 $-0.95 $-1.00 $-1.03 $-1.00 $-1.08 $-0.92 $-0.99 $-0.89 $-0.87 $-0.84 $-0.56 $-0.48 $-0.41 $-0.37 $-0.36 $-0.83 $-0.83
Book Value/Share $-0.31 $-0.31 $-0.61 $-0.61 $-0.61 $-0.61 $-1.11 $-1.04 $-1.02 $-0.90 $-0.99 $-0.87 $-0.85 $-0.84 $-0.67 $-0.57 $-0.55 $-0.52 $-0.50 $-0.49 $-0.85
Tangible Book/Share $-0.32 $-0.31 $-0.61 $-0.61 $-0.61 $-0.61 $-1.16 $-1.09 $-1.07 $-0.94 $-1.02 $-0.90 $-0.88 $-0.87 $-0.69 $-0.59 $-0.57 $-0.53 $-0.52 $-0.50 $-0.50
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.01 $0.02 $0.04 $0.06 $0.09 $0.11 $0.14 $0.14
FCF/Share $-0.63 $-0.72 $-0.78 $-0.86 $-0.94 $-0.97 $-1.03 $-0.95 $-0.89 $-0.77 $-0.67 $-0.61 $-0.62 $-0.62 $-0.54 $-0.44 $-0.40 $-0.34 $-0.31 $-0.29 $-0.29
OCF/Share $-0.58 $-0.66 $-0.69 $-0.73 $-0.78 $-0.80 $-0.84 $-0.81 $-0.77 $-0.69 $-0.62 $-0.58 $-0.60 $-0.60 $-0.53 $-0.43 $-0.39 $-0.34 $-0.31 $-0.29 $-0.29
Cash/Share $0.25 $0.25 $0.80 $0.80 $0.80 $0.79 $0.27 $0.25 $0.25 $0.22 $0.45 $0.40 $0.39 $0.38 $0.20 $0.18 $0.17 $0.16 $0.25 $0.24 $0.37
EBITDA/Share $-0.64 $-0.67 $-0.80 $-0.83 $-0.83 $-0.84 $-0.81 $-0.75 $-0.78 $-0.62 $-0.74 $-0.67 $-0.64 $-0.61 $-0.37 $-0.32 $-0.27 $-0.25 $-0.23 $-0.19 $-0.19
Debt/Share $0.72 $0.70 $1.63 $1.62 $1.62 $1.61 $1.79 $1.69 $1.65 $1.45 $1.23 $1.08 $1.06 $1.04 $0.69 $0.59 $0.57 $0.53 $0.89 $0.86 $0.86
Net Debt/Share $0.47 $0.46 $0.83 $0.83 $0.83 $0.82 $1.53 $1.44 $1.41 $1.24 $0.78 $0.68 $0.67 $0.66 $0.48 $0.42 $0.40 $0.37 $0.64 $0.62 $0.62
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -6.157
Altman Z-Prime snapshot only -15.422
Piotroski F-Score 2 2 3 2 3 3 1 2 3 3 5 4 4 4 3 3 3 3 5 4 4
Beneish M-Score 3.18 9.05 -44.85 -0.85 -0.14 -3.67 1.25 30.23 -92.93 -29.70 -53.55 -3.79 16.90 60.71 44.11 363.77 18.23 0.43 3.03 -1.41 -1.410
Ohlson O-Score snapshot only 5.174
Net-Net WC snapshot only $-0.67
EVA snapshot only $-220069610.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B-
Credit Score 20.00 20.00 16.57 16.82 16.84 17.13 12.81 12.82 12.81 12.81 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.000
Credit Grade snapshot only 16
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 15
Sector Credit Rank snapshot only 14

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms